Substance use disorders and Covid-19
The role of telehealth in treatment and research
Bibliographic Data
| ID | 15414035 |
|---|---|
| Authors | Bethea A Kleykamp (0000-0001-7117-0507, University of Rochester Medicine, corresponding author), Constance Guille (0000-0001-6004-3027, Medical University of South Carolina), Kelly S Barth (0000-0001-6339-6573, Medical University of South Carolina), Erin A Mcclure (0000-0001-9744-7818, Medical University of South Carolina) |
| Year | 2020 |
| Volume | 20 |
| Issue | 3 |
| Pages | 248-253 |
| Publication date | 2020-07-02 |
| Open Access | No |
| Type | ARTICLE |
| Venue | Journal of Social Work Practice in the Addictions (JOURNAL) |
| Journal identifiers | ISSN: 1533-256X • E-ISSN: 1533-2578 |
| Publisher | Taylor & Francis (PUBLISHER • GB) |
| DOI | 10.1080/1533256x.2020.1793064 |
| OpenAlex | W3081369442 |
| Language | EN |
| Citations received | 7 |
| References cited | 4 |
Telehealth, or the use of telecommunications and virtual technology to deliver health care and engage with patients outside of traditional health-care facilities, can play an important role in addressing the treatment and study of substance use disorders (SUDs) during the ongoing COVID-19 crisis. COVID-19 and related safety restrictions have thrust healthcare workers and researchers into a new reality of healthcare that relies heavily, or even exclusively, on telehealth methods. These changes have forced treatment providers and researchers to be agile in adopting these methods in order to maintain continuity of patient care and data collection. There are unique considerations that should be taken into account as telehealth practices continue to augment SUD care and research, even when restrictions have been lifted. Overall, we propose that telehealth can support innovation in treatment and research focused on SUDs and should be an integral part of our work, beyond COVID-19
2019-20 coronavirus outbreak · Coronavirus disease 2019 (COVID-19 · Disease · Health care · Pandemic · Political science · Psychiatry · Psychotherapist · Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 · Substance use · Telehealth · Telemedicine · COVID-19 and Mental Health · Digital Mental Health Interventions · Medicine · Psychology · Telemedicine and Telehealth Implementation · Internal Medicine · Virology
Telehealth Disparities in Outpatient Substance Use Disorder (SUD) Treatment among Medicaid Beneficiaries during Covid-19
Digital geographies of care
The Online Adaptation and Outcomes of a Family-Based Intervention Addressing Substance Use Disorders
Coping during the Covid-19 pandemic
Exploring the impacts of implicit context association and arithmetic booster in impulsivity reduction
Experiences with substance use disorder treatment during the Covid-19 pandemic
Volatile drug use and overdose during the first year of the Covid-19 pandemic in the United States
| Citations per year | 1.17 |
|---|---|
| Citation span | 2020 - 2025 (6) |
| Highly cited | No |